FDA Inspection 1120903 — Maude Group Inc.

Maude Group Inc. — FEI 3013986076

The FDA completed an inspection of Maude Group Inc. on March 13, 2020 in Brooklyn, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 5 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 13, 2020
Fiscal Year
2020
Product Type
Devices
Project Area
Compliance: Devices
Location
Brooklyn, NY (United States)

Citations

IDCFRDescription
1471321 CFR 820.198(a)Lack of or inadequate complaint procedures
232721 CFR 820.22Quality audits - Lack of or inadequate procedures
326921 CFR 820.80(b)Incoming acceptance records, documentation
366621 CFR 820.20(c)Management review - Lack of or inadequate procedures
48621 CFR 820.50(a)Evaluation of suppliers, contractors, etc., requirements